symptoms of cancer of the throat

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Tuesday, 31 July 2012

Melanoma Treatment Moves Forward in 2011

Posted on 05:00 by Unknown
Lynn Schuchter, MD, program leader for Penn's Melanoma Research Program says 2011 was the “year of melanoma,” one in which two important new agents were approved by the FDA (the first in over 40 years). It was in 2011, cancer research for melanoma began to make a significant difference for patients with advanced forms of melanoma.

2012 is emerging as a year in which researchers and clinicians are taking these new clinical approaches to the next level.

The two key areas are therapies targeted to specific genetic mutations and immunotherapy.

Dr. Schuchter and other melanoma experts at Penn believe we are only beginning to understand enough about how melanoma cells grow and spread to develop effective new treatments based.

Dr. Schuchter opened this year’s Focus On Melanoma Conference with an update on melanoma treatments and advances in melanoma research. Last year, the introduction of the drug vemuranefenib was the first big piece of news. Vemuranefenib works by inhibiting BRAF gene activity in the approximately 50% of melanoma patients who in whom this gene is "broken." The drug is powerful, producing often dramatic responses in patients with advanced melanoma, but it almost always stops working after a period of six to 18 months. This phenomenon --in which patients respond well to a drug for a period of time only to see the cancer come back or start growing again--is called resistance, and is one of the most perplexing barriers to developing effective, lasting cancer treatments.

Cancer researchers are beginning to understand the amazingly complex mechanisms by which cancer cells become resistant.

In the case of BRAF inhibitors, this occurs when the melanoma cells in essence take a detour--an alternate pathway that allows them to avoid the STOP growing and dividing sign they encounter when BRAF activity is inhibited. The goal now is to combine the original drug, vemuranefenib, with other targeted agents that block these alternative pathways. A major clinical trial in which vemuranefenib is used with a drug known as a MEK inhibitor is showing very promising results, and will be featured at the 2012 meeting of the American Society of Clinical Oncology (ASCO). This is one of what will be many clinical trials aimed at overcoming the problem of resistance with targeted therapies in malignant melanoma. A surprising, but welcome finding in this trial, is that the combined therapy is not only superior to vemuranefenib alone but the incidence of side effects, especially those related to skin problems, is significantly reduced.

Immunotherapy is the other very promising area in treating melanoma. Researchers have known for a long time that the immune system is active in trying to seek out and destroy melanoma cells—while on the other hand the melanoma cells are effective in hiding from the immune system. New therapies are focused on making melanoma cells more visible and increasing the level of immune activity. Last year's new agent in the immunotherapy arena is known as ipilumubab (ipi). The drug works very well for some patients, often resulting in delayed responses, meaning that in the first several weeks of therapy, the melanoma will actually grow--but then begin to regress and sometimes disappear completely. Ipi also stimulates an auto-immune response that can cause a wide range of side effects, ranging from colitis to endocrine problems to inflammations of the skin and liver.

The current goal for ipi is to understand in advance which patients should receive this drug and when. Right now, ipi is only approved for late stage melanoma patients and for a limited course of therapy. For melanoma patients at high risk of recurrence, researchers are very interested in finding out whether this drug can be effective as additional therapy once primary cancer treatment is completed (know as adjuvant therapy) -- or whether it can be used as maintenance therapy. A big question is whether ipi can be successfully combined with BRAF inhibitors— Currently they are given sequentially.

New insight in the ways in which the immune system interacts with melanoma cells is also opening the door to developing new agents and approaches to immunotherapy. PD-1 is an antibody similar to ipi which has been shown to be very active in early trials--without the autoimmune response. Another technique that is being successfully used to treat leukemias is now on the cusp of being used for melanomas as well. This involves extracting t-cells from the patient, "supercharging" them in the lab and then injecting them back into the patient--another example of an emerging new therapy that is both highly tailored and personalized.

As Dr. Schuchter said in concluding her remarks, "These are not conversations we were having nine years ago when we first started this conference. We have a lot more to do, but these are exciting times."

Watch all of the presentations from the 2012 Focus On Melanoma Conference here. 

Learn more about treatment for melanoma at Penn in Philadelphia.
Email ThisBlogThis!Share to XShare to Facebook
Posted in melanoma | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Radiating Love
    When Neha Vapiwala, MD , and John P. Plastaras, MD, PhD , met during the Perelman School of Medicine’s residency program in radiation oncolo...
  • Megan's Story: From Sarcoma to Survivor
    "When I came to the Abramson Cancer Center (ACC) with stage 2 synovial sarcoma, I needed hope and I needed help. Dr. Kristy Weber treat...
  • Cancer-Fighting Recipe: Anytime Crunch
    The orange zest found in this "Anytime Crunch" provides an instant mood lifter as well as flavor elevator for your yogurt, cottage...
  • Positivity and Hope at the Abramson Cancer Center #CSD14
    Cancer Survivor’s Day is a day to celebrate life with and after cancer. Every person diagnosed with cancer is considered a survivor, and tod...
  • Cancer-Fighting Recipe: Springtime Vegetable Slaw
    Warmer weather is a perfect time to eat light, and take advantage of vegetables that pack a healthy punch. This recipe for vegetable slaw...
  • Learn About Skin Cancer Prevention at Penn
    Penn’s Abramson Cancer Center invites you and your loved ones to attend CANPrevent Skin Cancer, a free educational conference for anyone i...
  • A Toast to Hope and Progress at the 10th Annual Focus on Melanoma Conference
    Christine Wilson, cancer survivor, shares her experiences from the Abramson Cancer Center’s 2013- Focus Melanoma and CAN Prevent Skin Cancer...
  • The Benefits of Whole Grains
    Whole grains provide many cancer-fighting benefits and help with bowel regularity, decrease spikes in blood sugar and make you feel fuller l...
  • The Saracini Family’s Own Miracle on 34th Street
    After the terrorist attacks on September 11, 2001, the world became a very different place. For Ellen Saracini and her daughters, the event...
  • Julia’s Story: How a Pair of Genes Changed My Life
    My story began in June 2009 when I found out that the word “genes” can mean more than something you wear on the weekends. The symptoms that ...

Categories

  • Abramson-Cancer-Center
  • acupuncture for cancer symptoms
  • alcohol
  • American Cancer Society
  • amyloidosis
  • amyloidosis clinic
  • Angelina Jolie
  • ASCO
  • Basser
  • Basser-PR
  • Basser-Research-Center
  • bone marrow transplant
  • bone-marrow-donation
  • brain cancer
  • brain tumor
  • brain-cancer
  • BRCA
  • BRCA1
  • BRCA2
  • breast-cancer
  • breastfeeding
  • cancer
  • cancer-prevention
  • cancer-risk
  • Cancer-survivorship
  • cancer-treatment
  • caregivers
  • Carlette
  • CART 19
  • Center-for-personalized-diagnostics
  • cervical-cancer
  • check-your-skin
  • chemoprevention; breast-cancer
  • chemotherapy
  • childhood-cancer
  • children
  • chronic-lymphocytic-leukemia
  • colon-cancer
  • colonoscopy
  • colorectal-cancer
  • colposcopy
  • complementary-therapies
  • conferences
  • Cure Is Within
  • CVS
  • cysts
  • dcis
  • diagnosis
  • e-cigarettes
  • e-connects
  • Emily Ko
  • endometrial-cancer
  • esophageal-cancer
  • events
  • exercise
  • eye
  • Father's Day
  • fertility
  • focus on conference
  • food
  • FORCE
  • gastroenterology
  • gastrointestinal-cancer
  • gene-mutation
  • genetic-counseling
  • genitourinary-cancer
  • geriatric-oncology
  • guest-blog
  • gynecologic
  • hair loss
  • head and neck cancer
  • head-and-neck-cancer
  • HEADSTRONG Foundation
  • Hodgkin-lymphoma
  • holidays
  • Hope for Young Widows
  • HPV
  • immunotherapy
  • integrative-medicine
  • Jane the Writer
  • joan-karnell-cancer-center
  • John Kosteva
  • kale
  • Kamp-Kesem
  • kidney-cancer
  • leukemia
  • liver-cancer
  • livestrong
  • lung cancer
  • lung-cancer
  • lung-cancer-awareness-month
  • lymphedema
  • male-breast-cancer
  • mammograms
  • manicure
  • MDS
  • melanie-gaffney
  • melanoma
  • men's-health
  • mesothelioma
  • mindfulness-program
  • mint
  • Mothers-Day
  • Muir-Torre Syndrome
  • multiple-myeloma
  • myeloma
  • National Lung Screening Trial
  • NETs
  • neuroendocrine-tumor
  • nicotine-addiction
  • non-Hodgkin-lymphoma
  • nursing
  • nutrition
  • obesity
  • Office of Diversity
  • OncoLink
  • oncology careers
  • oral-cancer
  • oral-health
  • ovarian-cancer
  • pain management for cancer
  • pancreatic-cancer
  • patient
  • patient-story
  • pdt
  • peas
  • Penn Medicine Valley Forge
  • Penn proton therapy
  • pet-cancer
  • philanthropy
  • photodynamic-therapy
  • potatoes
  • prevention
  • previvor
  • prostate-cancer
  • proton-therapy
  • PSA-test
  • quality
  • QVC
  • radiation-therapy
  • raloxifene
  • recipes
  • rectal-cancer
  • Reiki
  • relationships
  • Ride to Conquer Cancer
  • risk
  • RTCC
  • Sarcoma
  • screening
  • skin-cancer
  • smoking
  • smoking-cessation
  • Stand-Up-2-Cancer
  • stomach-cancer
  • sunscreens
  • supplements
  • support groups
  • surgery
  • survivor
  • survivorship
  • tamoxifen
  • testicular-cancer
  • thyroid-cancer
  • tobacco
  • tonsil-cancer
  • TORS
  • Twitter
  • uterine-cancer
  • Valentine's Day Chocolate Recipe
  • Valentines Day
  • vitamins
  • Vivian Stringer
  • weight-loss
  • wish-upon-a-wedding
  • women's health
  • world cancer day
  • yoga
  • Young-Friends-of-ACC

Blog Archive

  • ►  2014 (84)
    • ►  July (7)
    • ►  June (15)
    • ►  May (10)
    • ►  April (10)
    • ►  March (23)
    • ►  February (10)
    • ►  January (9)
  • ►  2013 (230)
    • ►  December (16)
    • ►  November (19)
    • ►  October (24)
    • ►  September (19)
    • ►  August (8)
    • ►  July (13)
    • ►  June (14)
    • ►  May (24)
    • ►  April (27)
    • ►  March (26)
    • ►  February (22)
    • ►  January (18)
  • ▼  2012 (186)
    • ►  December (22)
    • ►  November (21)
    • ►  October (20)
    • ►  September (17)
    • ►  August (10)
    • ▼  July (16)
      • Melanoma Treatment Moves Forward in 2011
      • Age and Melanoma
      • Avid Cyclist Rides Bike to Proton Therapy Treatmen...
      • How to Understand Grocery Store Lingo
      • Treatment for Lymphedema
      • When is Less More for Melanoma Surgery
      • Mediterranean Quinoa Salad
      • Wigs for Hair Loss From Chemotherapy
      • Preventing Lymphedema
      • 5 Tips to Avoid Caregiver Burnout
      • New Treatment at Penn Destroys Mesothelioma
      • Learn About Mesothelioma Treatment in Philadelphia...
      • Penn Leads the Way in Treatment for Mesothelioma
      • What is Photodynamic Light Therapy?
      • How to Get Vitamin D Without the Sun
      • How to Find a Lymphedema Specialist
    • ►  June (19)
    • ►  May (21)
    • ►  April (21)
    • ►  March (19)
Powered by Blogger.

About Me

Unknown
View my complete profile